MicroRNA-dependent regulation of ckit in cutaneous melanoma

被引:98
作者
Igoucheva, O. [1 ]
Alexeev, V. [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, BLSB, Philadelphia, PA 19107 USA
关键词
cKit; MicroRNA; Cutaneous melanoma; Melanocytes; mir-221; KIT; ACTIVATION; EXPRESSION; PROTEIN; CELLS; PROLIFERATION; MUTATIONS; CARCINOMA; APOPTOSIS; PATHWAY;
D O I
10.1016/j.bbrc.2008.12.152
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Loss of ckit receptor in Cutaneous melanomas was attributed to the down-regulation of AP2 transcription factor. Our analysis of 27 melanoma cell lines showed no correlation between AP2 and c-kit expression. Suggesting a post-transcriptional mechanism of cKit clown-modulation, we performed genome-wide microRNA (miRNA) expression profiling and found that several miRNA species are commonly up-regulated in melanomas. Among them was mir-221, which can directly interact with c-kit 3'UTR and inhibit cKit protein translation. Observed inverse correlation of the c-kit and mir-221 expression in various melanocytic cells pointed to its involvement in regulation of cKit in melanoma. Moreover, a series of functional assays demonstrated that mir-221 could directly inhibit cKit, p27(Kip1) and, possibly, other pivotal proteins in melanoma. Collectively, the studies presented here indicate that mir-221 Could be a novel therapeutic target for the treatment of cutaneous melanoma. They also suggest that regulation of expression and functional activity of identified up-regulated miRNAs should be further studied in the context of malignant melanoma. (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:790 / 794
页数:5
相关论文
共 17 条
[11]   AP-2γ protein expression in intratubular germ cell neoplasia of testis [J].
Hong, SM ;
Frierson, HF ;
Moskaluk, CA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (06) :873-877
[12]  
Huang SY, 1996, ONCOGENE, V13, P2339
[13]   Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction [J].
Lennartsson, J ;
Blume-Jensen, P ;
Hermanson, M ;
Pontén, E ;
Carlberg, M ;
Rönnstrand, L .
ONCOGENE, 1999, 18 (40) :5546-5553
[14]   An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues [J].
Liu, CG ;
Calin, GA ;
Meloon, B ;
Gamliel, N ;
Sevignani, C ;
Ferracin, M ;
Dumitru, CD ;
Shimizu, M ;
Zupo, S ;
Dono, M ;
Alder, H ;
Bullrich, F ;
Negrini, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) :9740-9744
[15]   Determinants of BRAF mutations in primary melanomas [J].
Maldonado, JL ;
Fridlyand, J ;
Patel, H ;
Jain, AN ;
Busam, K ;
Kageshita, T ;
Ono, T ;
Albertson, DG ;
Pinkel, D ;
Bastian, BC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (24) :1878-1880
[16]   Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression [J].
Smalley, Keiran S. M. ;
Contractor, Rooha ;
Nguyen, Thiennga K. ;
Xiao, Min ;
Edwards, Robin ;
Muthusamy, Viswanathan ;
King, Alastair J. ;
Flaherty, Keith T. ;
Bosenberg, Marcus ;
Herlyn, Meenhard ;
Nathanson, Katherine L. .
CANCER RESEARCH, 2008, 68 (14) :5743-5752
[17]   Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation [J].
Timokhina, I ;
Kissel, H ;
Stella, G ;
Besmer, P .
EMBO JOURNAL, 1998, 17 (21) :6250-6262